Longitudinal short-term assessments of single- and multi-protein disease activity biomarkers to determine reliability and the minimum detectable change in people with clinically stable RRMS
Published online on May 07, 2026
Abstract
Multiple Sclerosis Journal, Ahead of Print.
Objectives:This study aims to evaluate the ability of a multi-protein biomarker score to characterize clinical stability in relapsing-remitting multiple sclerosis (RRMS) compared to that of single-protein markers.Methods:Serum was collected from 62 out of ...
Objectives:This study aims to evaluate the ability of a multi-protein biomarker score to characterize clinical stability in relapsing-remitting multiple sclerosis (RRMS) compared to that of single-protein markers.Methods:Serum was collected from 62 out of ...